Decoding Cancer: How Genomics is Changing Public Health
"A deep dive into how genomic research is reshaping cancer prevention, diagnosis, and treatment for a healthier future."
For decades, cancer has been a formidable public health challenge, ranking as the second leading cause of death worldwide. While claims suggest a decline in cancer death rates due to increased awareness, early detection, and improved treatments, the reality is that cancer remains a major concern. It accounts for 23% of total deaths, marginally behind heart disease at 24%.
Lung, breast, prostate, and colorectal cancers are the most prevalent, collectively contributing to nearly half of all cancer-related deaths. Among these, lung cancer is particularly devastating, responsible for over a quarter of all cancer fatalities. Interestingly, men generally experience higher cancer mortality rates than women, except in specific age groups.
The interplay between lifestyle factors (diet, hormone exposure, physical activity) environmental risks (radiation, chemicals) and human genomics is critical in understanding cancer epidemiology. In 2010, a staggering 43% of cancer cases and approximately 50% of cancer deaths were attributed to lifestyle and environmental factors, highlighting the potential for prevention and personalized intervention strategies.
Cancer Data for Public Health
The CDC says cancer data are used to understand cancer rates and trends, support research, measure progress in cancer control and prevention, focus action on eliminating disparities, and improve outcomes. Researchers can analyze de-identified U.S. cancer incidence data free of charge through the U.S. Cancer Statistics Public Use Database. The National Cancer Institute's Cancer Research Data Commons also provides access to datasets, including secure cloud workspaces where researchers can bring their own data for comparative analysis. Together, these resources support surveillance, research, and data-informed public health action.
From One-Size-Fits-All to Precision
Precision public health recognizes the limitations of a one-size-fits-all approach and accounts for heterogeneity within and across populations. State health agencies can strengthen public health genomics by planning and evaluating activities through implementation-science frameworks, including the Doyle et al. outcome framework. Reviews of personalized cancer prevention identify opportunities for population-level genomic screening, but translating research findings into routine clinical practice remains a major bottleneck. Limited funding, regulatory complexity, and unequal access to care add systemic constraints.
From Cancer History to Genomic Maps
The National Cancer Institute's milestone timeline presents landmark discoveries across roughly 250 years of efforts to understand and combat cancer, a disease known to humanity for thousands of years. Early cancer genomics projects helped lead to the formation of the NCI's Office of Cancer Genomics, whose longstanding goal is to build resources for the research community. The Pan-Cancer Analysis of Whole Genomes study used data from the International Cancer Genome Consortium and The Cancer Genome Atlas to examine how changes throughout the genome contribute to cancer development, growth, and spread.
The Genomic Revolution in Cancer Care
The special issue "Cancer Genomics and Public Health" compiles systematic reviews, perspectives, and original research articles that delve into the intersection of cancer genomics and public health. The research explores informatics, knowledge bases, new technologies and strategies to fight cancer.
- Personalized Medicine: Schütte and colleagues advocate for personalized medicine strategies in cancer drug therapy, emphasizing comprehensive analyses of patient and tumor DNA and RNA.
- PDX Models: Perales-Patón and collaborators explore patient-derived xenograft (PDX) mouse models to tailor treatments for pancreatic ductal adenocarcinoma (PDAC), offering a way to test treatments and select therapies.
- Early Detection: Malats and coworkers underscore the importance of genomics in cancer prevention and early detection, identifying genetic markers for high-risk populations.
Mapping Cancer's Complexity
Recent cancer-genomics reviews are examining the spatial dimensions of cancer evolution, including cancer subclonal structure and tissue architecture. Other current work focuses on how cancer-associated epigenetic and transcriptional dysregulation generates immunogenic nucleic acids that may limit tumor progression. A 2026 review highlights sequencing platforms, transcriptomic profiling, liquid biopsy, and functional genomic screening as major technological developments. These research directions expand genomic analysis from static mutation lists toward tumor structure, regulation, and function.
The Implementation Gap
Precision public health depends on broad public participation, so its challenges are scientific and technical as well as communicative. Public health agencies have an important role in ensuring access to interventions that prevent disease, including evidence-based genomic recommendations. Yet cancer research continues to face biological, technological, and systemic limitations that can hinder effective therapies and better outcomes. These constraints show why promising genomic findings do not automatically become equitable public-health results.
Projects, Databases, and Discovery
A 2022 review describes the evolution of international public cancer genome projects and related databases and discusses their impact on cancer research. The NCI reports that genomic studies have expanded understanding of the wide variation in genetic and molecular changes found in cancer. Those projects have also generated new ideas for treatment and improved understanding of cancer's molecular causes. Viewed together, the sources present large-scale genome initiatives as both shared research infrastructure and a foundation for biological insight.
Turning Data into Action: The Future of Cancer Genomics
The surge in high-throughput data necessitates functional in silico analysis. Martín-Antoniano and colleagues introduce DoriTool, a user-friendly pipeline integrating biological data from various functional tools, facilitating the extraction of biologically meaningful insights.
A Shared Cancer Genomics Platform
A 2026 concept paper proposes a Medical and Public Health Cancer Genomics Platform for European research projects. The proposed platform would aggregate and share cancer-care data while making research-derived evidence and knowledge accessible to relevant stakeholders. Its central idea is to connect data resources, research, and public health use rather than treating genomic evidence as isolated within individual projects. The proposal remains a concept for organizing cancer-care knowledge and data.
Tracking Progress and New Signals
The Cancer Trends Progress Report, updated continually since its first issue in 2001, summarizes U.S. advances against cancer in relation to Healthy People targets set by the Department of Health and Human Services. It is intended for policymakers, researchers, and public health professionals and covers measures across the cancer-control continuum. Recent global epidemiology research highlights big data, genomics, and machine learning as innovative methods for studying cancer trends. That work also considers environmental, lifestyle, and social determinants of cancer outcomes.
Genomics Meets Health Systems
Progress in genomics has advanced patient care, but systemic barriers continue to limit the uptake of genomic medicine. The National Academies source frames these challenges and potential solutions from a laboratory perspective. This means that scientific progress alone does not determine whether genomic approaches reach patients. Laboratory capacity, health-system processes, and implementation conditions remain part of the broader public-health challenge.
Turning Data Into Public Benefit
The Bloomberg American Health Open Case Studies Project is designed to help current and future data scientists use real-world data to address leading public health challenges. A case study of hereditary cancers reports that public health achievements in promoting evidence-based genomic recommendations can inform future applications of genomics in public health. Together, these sources connect technical data work with implementation and prevention in communities. The human impact therefore depends on whether genomic knowledge is translated into usable public-health action.
Bhat and coworkers present 1-CMDb, a comprehensive database of genomic elements within one-carbon metabolism pathways. This database aims to facilitate the integration of information into large-scale network analyses, fostering a deeper understanding of tissue homeostasis.
Ultimately, this special issue on cancer genomics aims to underscore the significance of new technologies and information tools in improving outcomes for cancer patients. The hope is that the included articles will stimulate synergies, transforming information growth into knowledge growth and, ultimately, practical clinical implementation and beyond.